Cargando…
The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: A cohort study
BACKGROUND: Portal vein tumor thrombosis (PVTT) is a frequent complication of hepatocellular carcinoma (HCC), which leads to classification as advanced stage disease (regardless of the degree of PVTT) according to the Barcelona Clinic Liver Cancer Classification. For such patients, systemic therapy...
Autores principales: | Mähringer-Kunz, Aline, Steinle, Verena, Kloeckner, Roman, Schotten, Sebastian, Hahn, Felix, Schmidtmann, Irene, Hinrichs, Jan Bernd, Düber, Christoph, Galle, Peter Robert, Lang, Hauke, Weinmann, Arndt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104403/ https://www.ncbi.nlm.nih.gov/pubmed/33961627 http://dx.doi.org/10.1371/journal.pone.0249426 |
Ejemplares similares
-
Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: Prevalence and clinical significance
por: Mähringer‐Kunz, Aline, et al.
Publicado: (2021) -
Radiomics-Based Prediction of Future Portal Vein Tumor Infiltration in Patients with HCC—A Proof-of-Concept Study
por: Stoehr, Fabian, et al.
Publicado: (2022) -
Risk prediction in intrahepatic cholangiocarcinoma: Direct comparison of the MEGNA score and the 8(th) edition of the UICC/AJCC Cancer staging system
por: Hahn, Felix, et al.
Publicado: (2020) -
Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging
por: Hahn, Felix, et al.
Publicado: (2020) -
Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma
por: Mähringer-Kunz, Aline, et al.
Publicado: (2018)